Physician profile
Sima C Pandya
NPI 1588854723
$1,622.78
in general payments reported to CMS, 2019-2025
19 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $215 · 2021: $303 · 2022: $212 · 2023: $209 · 2024: $250 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $609.98 | 2019-2025 | Collagenase Santyl |
| Amgen INC. | $196.02 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $130.10 | 2019-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $124.31 | 2019-2020 | |
| Orthofix Medical, INC. | $98.96 | 2022-2024 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $88.42 | 2020-2023 | Jublia |
| Alfasigma USA, INC. | $52.02 | 2021-2022 | |
| Mimedx Group, INC. | $48.63 | 2024 | |
| Mayne Pharma Commercial LLC | $48.52 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $38.46 | 2021 | |
| Organogenesis INC. | $33.97 | 2023 | Puraply |
| Bioventus LLC | $26.66 | 2025 | Exogen Ultrasound Bone Healing System |
| Abbvie INC. | $23.46 | 2021 | |
| Treace Medical Concepts, INC. | $22.72 | 2023 | |
| Stryker Corporation | $19.80 | 2024 | Augment Injectable |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.70 | 2021 | |
| Pfizer INC. | $16.32 | 2019 | |
| United Therapeutics Corporation | $15.00 | 2021 | |
| Integra Lifesciences Corporation | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sima Pandya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.